This drug may stop Parkinson’s disease, human trials set for 2019
Various medications are available that help control symptoms of the disease, but thus far medical science has not produced a drug that can prevent or stop it.

That may change thanks to this latest work coming out of Johns Hopkins. According to a recent announcement from the university, researchers have created an experimental drug that slows down the progression of the disease and may entirely halt the degradation of brain cells. The new drug is said to be similar to compounds that are used in the treatment of diabetes.

The drug, called NLY01, was tested on live mouse models and cultures of human brain cells, where it was observed to block brain cell degradation that results from Parkinson’s disease. Unlike existing drugs, which target various symptoms of the disease, NLY01 targets the damage to cells that result in the symptoms.

This drug may stop Parkinson's disease, human trials set for 2�19